- Home
- FRPH vs PHAR Comparison
FRPH vs PHAR Comparison
Compare FRPH & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FRPH
- PHAR
- Stock Information
- Founded
- FRPH 1986
- PHAR 1988
- Country
- FRPH United States
- PHAR Netherlands
- Employees
- FRPH N/A
- PHAR N/A
- Industry
- FRPH Real Estate
- PHAR Biotechnology: Pharmaceutical Preparations
- Sector
- FRPH Finance
- PHAR Health Care
- Exchange
- FRPH Nasdaq
- PHAR Nasdaq
- Market Cap
- FRPH 576.6M
- PHAR 618.3M
- IPO Year
- FRPH N/A
- PHAR N/A
- Fundamental
- Price
- FRPH $30.54
- PHAR $8.20
- Analyst Decision
- FRPH
- PHAR Strong Buy
- Analyst Count
- FRPH 0
- PHAR 3
- Target Price
- FRPH N/A
- PHAR $27.00
- AVG Volume (30 Days)
- FRPH 27.0K
- PHAR 5.6K
- Earning Date
- FRPH 03-05-2025
- PHAR 03-13-2025
- Dividend Yield
- FRPH N/A
- PHAR N/A
- EPS Growth
- FRPH 45.62
- PHAR N/A
- EPS
- FRPH 0.40
- PHAR N/A
- Revenue
- FRPH $31,414,000.00
- PHAR $285,745,000.00
- Revenue This Year
- FRPH N/A
- PHAR $20.08
- Revenue Next Year
- FRPH N/A
- PHAR $9.22
- P/E Ratio
- FRPH $76.97
- PHAR N/A
- Revenue Growth
- FRPH 4.04
- PHAR 30.64
- 52 Week Low
- FRPH $26.99
- PHAR $6.65
- 52 Week High
- FRPH $33.00
- PHAR $13.20
- Technical
- Relative Strength Index (RSI)
- FRPH 54.78
- PHAR 36.29
- Support Level
- FRPH $30.50
- PHAR $8.49
- Resistance Level
- FRPH $31.39
- PHAR $9.35
- Average True Range (ATR)
- FRPH 0.59
- PHAR 0.55
- MACD
- FRPH 0.11
- PHAR -0.17
- Stochastic Oscillator
- FRPH 69.65
- PHAR 12.14
About FRPH FRP Holdings Inc.
FRP Holdings Inc is a holding company engaged in various real estate businesses. The company's business segments are Leasing and management of commercial properties owned by the company (the Industrial/Commercial Segment); Leasing and management of mining royalty land owned by the company (the Mining Royalty Lands Segment); real property acquisition, entitlement, development and construction for apartment, retail, warehouse, and office buildings either alone or through joint ventures (the Development Segment); ownership, leasing and management of buildings through joint ventures (the Multifamily Segment).
About PHAR Pharming Group N.V.
Pharming Group is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. It is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines to serve the unserved rare disease patients. Its product includes Ruconest. The revenue is generated from the United States.